logo
After years of delays, new Acelas launching on August 28

After years of delays, new Acelas launching on August 28

Washington Post07-08-2025
New Amtrak Acela trains, delayed for years over production and testing issues, are coming to the Northeast Corridor on Aug. 28, the agency announced Friday.
In a statement, Amtrak President Roger Harris called the 28 new train sets 'an evolution' that will set 'a new standard for American train travel.' Only five of the trains will go into service immediately on the route from Boston to D.C.; the rest will be added to the fleet over the next two years.
The new Acelas can reach top speeds of 160 mph versus 150 on the older model and tilt around curves more easily. The current Acela takes two hours and 50 minutes to get from D.C. to New York; Amtrak's near-term plans estimate a trip can be 20 minutes faster. The trains will also have upgraded WiFi connectivity, brighter lighting, bigger windows and more comfortable seats, the agency said, and carry 25 percent more riders while using less energy. Every seat will have its own USB port.
'It's a fundamentally better experience than anything Americans have been able to travel on to date in this country,' Laura Mason, who is in charge of major capital projects at Amtrak, said in a video promoting the change.
The current Acelas are a quarter-century old, and replacements were supposed to roll out in 2021. But they were delayed for years in part due to difficulties posed by the aging track and catenary wire along the corridor, as well as logistical issues with testing the trains. The disruption of the coronavirus pandemic caused further problems.
'The legacy Acela trainsets are past their useful service life,' Amtrak's inspector general wrote in 2023. 'Delays have already resulted in significant cost increases, operational impacts, and delayed revenue.'
Ridership on the Acela, Amtrak's highest-speed service, was at an all-time high before the pandemic. While overall Amtrak ridership has bounced back, more affordable options have been growing faster than the premier trains.
The new trains were built by French manufacturer Alstom at a plant in Hornell, New York, at a cost of $2.5 billion, including maintenance. Amtrak says it will also have new trains in service on the East Coast and in the Pacific Northwest next year, part of a $7.3 billion upgrade.
President Joe Biden's infrastructure bill provided funding for long-overdue repairs and improvements along the Northeast Corridor and elsewhere. Next month will also see the reopening of the line between Mobile, Alabama, and New Orleans for the first time since Hurricane Katrina.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Paul Tudor Jones Makes Significant Moves with SPDR S&P 500 ETF Trust
Paul Tudor Jones Makes Significant Moves with SPDR S&P 500 ETF Trust

Yahoo

time24 minutes ago

  • Yahoo

Paul Tudor Jones Makes Significant Moves with SPDR S&P 500 ETF Trust

Exploring the Latest 13F Filing for Q2 2025 Paul Tudor Jones (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Paul Tudor Jones (Trades, Portfolio) II, founder and chief investment officer of Boston-based Tudor Investment Group, is one of the pioneers of the modern-day hedge fund industry. Jones began his career in the cotton pits before forming the firm in 1980. The guru was eager to create a firm differentiated by a steadfast dedication to client objectives and guided by strong ethics and values. While Tudor Investment is best known for its rich history in discretionary macro trading, the firm also has significant experience and capabilities in model-driven and systematic investment approaches. Management believes that firms must continually innovate in order to compete in rapidly evolving markets and thus, commits significant resources to research and development across a variety of strategies in order to expand the firm's edge. Ultimately, Tudor seeks to generate consistent returns for both client and proprietary capital through the use of best-in-class research, trading, and investment techniques. Warning! GuruFocus has detected 7 Warning Sign with MSFT. Summary of New Buy Paul Tudor Jones (Trades, Portfolio) added a total of 528 stocks, among them: The most significant addition was Copart Inc (NASDAQ:CPRT), with 1,690,402 shares, accounting for 0.18% of the portfolio and a total value of $82,948,030 million. The second largest addition to the portfolio was Alphabet Inc (NASDAQ:GOOG), consisting of 417,111 shares, representing approximately 0.16% of the portfolio, with a total value of $73,991,320 million. The third largest addition was McDonald's Corp (NYSE:MCD), with 235,681 shares, accounting for 0.15% of the portfolio and a total value of $68,858,920 million. Key Position Increases Paul Tudor Jones (Trades, Portfolio) also increased stakes in a total of 524 stocks, among them: The most notable increase was SPDR S&P 500 ETF Trust (SPY), with an additional 1,886,777 shares, bringing the total to 1,987,813 shares. This adjustment represents a significant 1,867.43% increase in share count, a 2.53% impact on the current portfolio, with a total value of $1,228,170,260. The second largest increase was T-Mobile US Inc (NASDAQ:TMUS), with an additional 368,066 shares, bringing the total to 422,171. This adjustment represents a significant 680.28% increase in share count, with a total value of $100,586,460. Summary of Sold Out Paul Tudor Jones (Trades, Portfolio) completely exited 498 holdings in the second quarter of 2025, as detailed below: Broadcom Inc (NASDAQ:AVGO): Paul Tudor Jones (Trades, Portfolio) sold all 587,265 shares, resulting in a -0.33% impact on the portfolio. Intra-Cellular Therapies Inc (ITCI): Paul Tudor Jones (Trades, Portfolio) liquidated all 621,815 shares, causing a -0.27% impact on the portfolio. Key Position Reduces Paul Tudor Jones (Trades, Portfolio) also reduced positions in 414 stocks. The most significant changes include: Reduced iShares Russell 2000 ETF (IWM) by 3,523,473 shares, resulting in a -94.29% decrease in shares and a -2.34% impact on the portfolio. The stock traded at an average price of $201.21 during the quarter and has returned 9.57% over the past 3 months and 3.44% year-to-date. Reduced Kellanova (NYSE:K) by 1,558,345 shares, resulting in a -80.38% reduction in shares and a -0.43% impact on the portfolio. The stock traded at an average price of $81.73 during the quarter and has returned -1.42% over the past 3 months and 0.28% year-to-date. Portfolio Overview At the second quarter of 2025, Paul Tudor Jones (Trades, Portfolio)'s portfolio included 3,177 stocks, with top holdings including 2.67% in SPDR S&P 500 ETF Trust (SPY), 0.6% in ISHARES BITCOIN TR (NASDAQ:IBIT), 0.35% in Frontier Communications Parent Inc (NASDAQ:FYBR), 0.35% in Spirit AeroSystems Holdings Inc (NYSE:SPR), and 0.31% in Apple Inc (NASDAQ:AAPL). The holdings are mainly concentrated in all 11 industries: Technology, Industrials, Financial Services, Consumer Cyclical, Healthcare, Communication Services, Consumer Defensive, Energy, Basic Materials, Real Estate, and Utilities. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.

Global Digital Pathology Market to Reach $13.7 Billion in 2029
Global Digital Pathology Market to Reach $13.7 Billion in 2029

Yahoo

timean hour ago

  • Yahoo

Global Digital Pathology Market to Reach $13.7 Billion in 2029

'BCC Research explores how AI-driven workflows, strategic investment, and cross-regional collaboration are shaping the digital pathology market of the future.' Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote pathology consultations, leading players such as Roche, Nikon Instruments, and Indica Labs are advancing innovations that optimize workflows, increase diagnostics speed, and improve collaboration across regions. According to the report, the increasing incidence of cancer, widespread adoption of digital workflows, and rising investments in cloud-based imaging and analytics are reshaping the pathology value chain. The global market is expected to grow from $7.8 billion in 2024 to $13.7 billion by the end of 2029, growing at a CAGR of 11.9% from 2024 to 2029. As North America maintains leadership and Europe expands its clinical and research integration, the Asia-Pacific market is growing rapidly. Vendors must navigate technical integration, cybersecurity, and cost-access barriers to fully capitalize on these opportunities. Market Insights and Strategic Trends Shaping Growth Digital pathology is transitioning from niche adoption to global scaling. Hospitals and diagnostic labs are increasingly investing in AI-enabled image analysis, real-time collaboration tools, and teleconsultation platforms. Clinical utility is expanding beyond cancer diagnosis into chronic disease management, R&D, and education. With healthcare systems under pressure to reduce turnaround time and increase diagnostic accuracy, digital platforms offer a scalable, cost-effective solution to optimize pathology workflows. (Chapter 2: Market Overview; Chapter 3: Market Dynamics) Financial investment in digital pathology continues to rise, driven by venture capital, public health spending, and cross-border collaborations. Funding rounds and strategic alliances are fueling innovation in smart imaging, automated analysis, and cloud-integrated platforms. As laboratories seek cost-effective alternatives to conventional microscopy, companies are rolling out tailored packages that integrate storage, analysis, and compliance tools. (Chapter 3: Market Dynamics; Chapter 6: Emerging Trends and Technologies) Many of the leading companies are pursuing dual-track strategies—expanding both product portfolios and regional presence. For instance, global manufacturers are offering tiered solutions for academic centers and high-throughput hospital labs. At the same time, mergers, acquisitions, and co-development partnerships are being used to penetrate new regions and clinical verticals. These strategies not only accelerate commercialization but also support long-term financial sustainability. (Chapter 9: Competitive Landscape; Chapter 5: Market Segmentation Analysis) Investments are particularly noticeable in image analytics, where AI and machine learning are enabling more precise quantification of biomarkers and improved pattern recognition. Cloud-based platforms are receiving strategic focus, allowing remote access, reduced IT burden, and scalable deployment. Organizations are also adopting outcome-based business models, offering solutions-as-a-service to improve affordability. (Chapter 6: Emerging Trends and Technologies; Chapter 9: Competitive Landscape) Digital pathology vendors are aligning with ESG priorities, embedding sustainability into device development and supply chain strategies. This includes reducing energy consumption, enabling remote workflows that limit physical transport of samples, and improving data transparency in diagnostic reporting. These commitments are becoming important differentiators in procurement processes. (Chapter 7: ESG Developments) Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $7.0 billion Market size forecast $13.7 billion Growth rate CAGR of 11.9% for the forecast period of 2024-2029 Segments covered System, Type, Application, End User, and Region Regions covered North America, Asia-Pacific, Europe, Rest of the World Countries covered U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, China, South Korea, Australia, South America, and Middle East and Africa Market drivers Cost-effectiveness driving expansion. Growing adoption of digital pathology to enhance lab efficiency. Increasing incidence of cancer. Increasing investments and funding in digital pathology. Additional Insights: Paige's AI Breakthrough: In January 2024, Paige launched Virchow, a groundbreaking solution built on its Pathology Foundation Model. Developed using Microsoft's computational infrastructure, Virchow is capable of detecting cancer across 17 tissue types—including skin, lung, gastrointestinal, and rare tumor variants. Prov-GigaPath Sets New Standards: The AI-powered Prov-GigaPath model represents a major advances in digital pathology. Leveraging vision transformer architecture and real-world datasets, it enables enhanced mutation prediction, cancer subtyping, and vision-language tasks, tackling challenges such as data scarcity and slide complexity. Market leaders include: 3DHistech Ltd. Apollo Enterprise Imaging Corp. Clinisys Inc. Corista F. Hoffmann-La Roche Ltd. Fujifilm Holdings Corp. Huron Technologies International Inc. Indica Labs LLC. Koninklijke Philips N.V. Leica Biosystems Nussloch GmbH Ligolab Information Systems Mikroscan Technologies Inc. Nikon Instruments Inc. Visiopharm A/S Xifin Inc. Get your copy of the report directly from BCC Research. To request more information or complete your purchase, connect with us at info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. CONTACT: BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Fly E-Bike Expands to Boston with New Store Opening
Fly E-Bike Expands to Boston with New Store Opening

Yahoo

time2 hours ago

  • Yahoo

Fly E-Bike Expands to Boston with New Store Opening

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Fly-E Group, Inc. (Nasdaq: FLYE) ('Fly-E' or the 'Company'), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced the grand opening of its newest retail location in Boston, Massachusetts. The new store, now fully operational, marks the Company's continued expansion in the Northeastern United States and underscores its mission to make safe, reliable, and eco-friendly transportation accessible to more communities. The Boston store offers Fly E-Bike's full lineup of electric bikes, e-scooters, and accessories, with on-site services. Designed to meet the needs of both commuters and delivery professionals, Fly E-Bike's products combine technology with practical, user-friendly design for urban mobility. Mr. Zhou (Andy) Ou, Chairman and Chief Executive Officer of Fly-E, remarked, 'Boston is an ideal city for electric two-wheelers, with its vibrant neighborhoods, busy streets, and growing demand for sustainable transportation. By bringing Fly E-Bike to Boston, we are not only providing residents with a safer, greener, and more efficient way to travel, but also taking another important step in our long-term expansion strategy across key U.S. markets.' The new store is part of Fly E-Bike's growing retail network, which now spans more than 40 locations across North America, including New York, New Jersey, and other major metropolitan areas. The Company remains focused on expanding into key markets with strong potential for electric mobility adoption. Boston Store Details:Address: 41 West Street, Suite 100, Boston, MA 02111 Business Hours: 10:00 AM – 7:00 PMPhone Number: (929) 682-4315 About Fly-E Group, Inc. Fly-E Group, Inc. is an electric vehicle company that is principally engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes and electric under the brand "Fly E-Bike." The Company's commitment is to encourage people to incorporate eco-friendly transportation into their active lifestyles, ultimately contributing towards building a more environmentally friendly future. For more information, please visit the Company's website: Forward-Looking Statements Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as "approximates," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results, and that the forward-looking statements contained in this press release are subject to the risks set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), including the section under "Risk Factors" of its most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2025, filed with the SEC on July 15, 2025. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. For investor and media inquiries, please contact:Fly-E Group, Relations DepartmentEmail: ir@ Ascent Investor Relations LLCTina XiaoPhone: +1-646-932-7242Email: investors@ in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store